CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
6.70
-0.29 (-4.15%)
At close: Aug 8, 2025, 4:00 PM
6.80
+0.10 (1.49%)
After-hours: Aug 8, 2025, 7:58 PM EDT
CNS Pharmaceuticals Market Cap
CNS Pharmaceuticals has a market cap or net worth of $3.55 million as of August 8, 2025. Its market cap has increased by 14.61% in one year.
Market Cap
3.55M
Enterprise Value
-9.29M
1-Year Change
14.61%
Ranking
Category
Stock Price
$6.70
Market Cap Chart
Since November 8, 2019, CNS Pharmaceuticals's market cap has decreased from $69.92M to $3.55M, a decrease of -94.92%. That is a compound annual growth rate of -40.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 3.55M | -48.71% |
| Dec 31, 2024 | 6.92M | 4.40% |
| Dec 29, 2023 | 6.63M | 109.26% |
| Dec 30, 2022 | 3.17M | -83.83% |
| Dec 31, 2021 | 19.60M | -51.07% |
| Dec 31, 2020 | 40.05M | -37.41% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 561.67B |
| Johnson & Johnson | 417.44B |
| AbbVie | 349.87B |
| Abbott Laboratories | 233.71B |
| AstraZeneca | 227.85B |
| UnitedHealth Group | 227.59B |
| Novartis AG | 225.61B |
| Novo Nordisk | 224.34B |